Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Jan 14:7:2.
doi: 10.1186/s13229-015-0062-8. eCollection 2016.

A randomized, placebo-controlled trial of D-cycloserine for the enhancement of social skills training in autism spectrum disorders

Noha F Minshawi  1 , Logan K Wink  2 , Rebecca Shaffer  2 , Martin H Plawecki  1 , David J Posey  3 , Hai Liu  4 , Sarah Hurwitz  5 , Christopher J McDougle  6 , Naomi B Swiezy  1 , Craig A Erickson  2
Affiliations
Randomized Controlled Trial

A randomized, placebo-controlled trial of D-cycloserine for the enhancement of social skills training in autism spectrum disorders

Noha F Minshawi et al. Mol Autism. .

Abstract

Background: Researchers have demonstrated that d-cycloserine (DCS) can enhance the effects of behavioral interventions in adults with anxiety and enhances prosocial behavior in animal models of autism spectrum disorders (ASD). This study extended upon this background by combining DCS with behavioral social skills therapy in youth with ASD to assess its impact on the core social deficits of ASD. We hypothesized that DCS used in combination with social skills training would enhance the acquisition of social skills in children with ASD.

Methods: A 10-week, double-blind, placebo-controlled trial of DCS (50 mg) given 30 min prior to weekly group social skills training was conducted at two sites. Children with ASD were randomized to receive 10 weeks (10 doses) of DCS or placebo in a 1:1 ratio.

Results: No statistically significant difference attributable to drug treatment was observed in the change scores for the primary outcome measure, the Social Responsiveness Scale (SRS), total score (p = 0.45), or on secondary outcome measures.

Conclusions: The results of this trial demonstrated no drug-related short-term improvement on the primary outcome measure, or any of the secondary outcome measures. However, an overall significant improvement in SRS total raw score was observed from baseline to end of treatment for the entire group of children with ASD. This suggests a need to further study the efficacy of the social skills training protocol. Limitations to the current study and areas for future research are discussed.

Trial registration: ClinicalTrials.govNCT01086475.

Keywords: Autism spectrum disorders; Social deficits; Social skills training; d-cycloserine.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Social responsiveness scale raw score across time points
See this image and copyright information in PMC

References

    1. Kanner L. Autistic disturbances of affective contact. Nervous Child. 1943;2:217–250. - PubMed
    1. CDC . Prevalence of autism spectrum disorder among children aged 8 years—autism and developmental disabilities monitoring network, 11 sites, United States. 2010. - PubMed
    1. Wink LK, Erickson CA, McDougle CJ. Pharmacologic treatment of behavioral symptoms associated with autism and other pervasive developmental disorders. Curr Treat Options Neurol. 2010;12(6):529–538. doi: 10.1007/s11940-010-0091-8. - DOI - PubMed
    1. Blankenship K, Stigler KA, Erickson CA, Posey DJ, McDougle CJ. Psychopharmacoloigcal treatment of autism. In: Amaral D, Dawson G, Geschwind D, editors. Autism spectrum disorders. New York: Oxford University Press; 2011. pp. 1194–1212.
    1. Posey DJ, Erickson CA, McDougle CJ. Developing drugs for core social and communication impairment in autism. Child Adolesc Psychiatr Clin N Am. 2008;17(4):787–801. doi: 10.1016/j.chc.2008.06.010. - DOI - PMC - PubMed

Publication types

MeSH terms

Associated data